Vycor Medical (VYCO) Cash from Discontinued Operations (2019 - 2026)

Vycor Medical (VYCO) has 8 years of Cash from Discontinued Operations data on file, last reported at 1117.0 in Q1 2026.

• On a quarterly basis, Cash from Discontinued Operations rose 2179.59% year-over-year to 1117.0 in Q1 2026; TTM through Mar 2026 was 1704.0, a 764.97% increase from a year earlier, with the FY2025 full-year figure at 636.0, up 154.4% from the prior year.
• Cash from Discontinued Operations for Q1 2026 stood at 1117.0, up from 308.0 in the prior quarter.
• Over the last five years, Cash from Discontinued Operations for VYCO reached as high as 1117.0 in Q1 2026 and fell as low as 1116.0 in Q2 2022.
• Historically, Cash from Discontinued Operations has averaged 65.65 across 5 years, with a median of 53.0 in 2024.
• Across the five-year window, Cash from Discontinued Operations slumped 287.82% in 2023 and surged 2179.59% in 2026, its largest moves.
• Year by year, Cash from Discontinued Operations stood at 322.0 in 2022, then jumped by 55.59% to 143.0 in 2023, then surged by 137.06% to 53.0 in 2024, then soared by 481.13% to 308.0 in 2025, then surged by 262.66% to 1117.0 in 2026.
• Per Business Quant data, the three most recent Cash from Discontinued Operations figures were 1117.0 in Q1 2026, 308.0 in Q4 2025, and 53.0 in Q3 2025.